Stay updated on Amivantamab Combo Therapy Clinical Trial
Sign up to get notified when there's something new on the Amivantamab Combo Therapy Clinical Trial page.

Latest updates to the Amivantamab Combo Therapy Clinical Trial page
- Check2 days agoChange DetectedNew May 2026 revision entries were added and the page version updated to v3.5.4, while April 2026 entries and the previous v3.5.3 revision were removed; this reflects a versioning update rather than substantive study information.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe revision label on the page was updated from v3.5.2 to v3.5.3, indicating a new revision of the page content. This signals a minor update to the study record, typically involving small edits or fixes without changing the underlying data.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe study location list was updated to 232 sites with new entries including Zhejiang University’s Second Affiliated Hospital (Hangzhou), Hunan Cancer Hospital, Beijing Cancer Hospital, and The Royal Marsden locations; references to 229 sites were removed.SummaryDifference0.3%

- Check52 days agoChange DetectedStudy locations were updated: City of Hope was removed and City of Hope 2 was added. This affects where participants can enroll and which sites are available for the study.SummaryDifference0.1%

- Check59 days agoChange DetectedA new PAPILLON Asia subgroup analysis article (Lung Cancer, 2026) was added to Publications, and the online-ahead-of-print listing for that article was removed; the bibliographic entry was updated.SummaryDifference0.0%

- Check66 days agoChange DetectedUpdated the page revision from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Amivantamab Combo Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab Combo Therapy Clinical Trial page.